These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12298120)

  • 1. Visual compatibility of argatroban with selected drugs.
    Hartman CA; Baroletti SA; Churchill WW; Patel P
    Am J Health Syst Pharm; 2002 Sep; 59(18):1784-5. PubMed ID: 12298120
    [No Abstract]   [Full Text] [Related]  

  • 2. Compatibility of argatroban injection with select antiarrhythmic drugs.
    Jakimczuk PJ; Churchwell MD; Howard MS; Mauro VF; Alexander KS; Boddu SH
    Am J Health Syst Pharm; 2014 Nov; 71(21):1831-2. PubMed ID: 25320130
    [No Abstract]   [Full Text] [Related]  

  • 3. Visual compatibility of abciximab with selected drugs.
    Baroletti S; Hartman C; Churchill W
    Am J Health Syst Pharm; 2002 Mar; 59(5):466-7. PubMed ID: 11887414
    [No Abstract]   [Full Text] [Related]  

  • 4. Visual compatibility of bivalirudin with selected drugs.
    Hartman CA; Faria CE; Mago K
    Am J Health Syst Pharm; 2004 Sep; 61(17):1774, 1776. PubMed ID: 15462247
    [No Abstract]   [Full Text] [Related]  

  • 5. Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion.
    Kambia NK; Luyckx M; Dine T; Dupin-Spriet T; Gressier B; Brunet C
    J Clin Pharm Ther; 2009 Feb; 34(1):25-31. PubMed ID: 19125900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual compatibility of oritavancin diphosphate with selected coadministered drugs during simulated Y-site administration.
    Kumar A; Mann HJ
    Am J Health Syst Pharm; 2010 Oct; 67(19):1640-4. PubMed ID: 20852166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents.
    Newland AM; Mauro VF; Alexander KS
    Am J Health Syst Pharm; 2009 Jun; 66(11):986-7. PubMed ID: 19451606
    [No Abstract]   [Full Text] [Related]  

  • 8. Physical compatibility of levetiracetam injection with heparin, dobutamine, and dopamine.
    Cruz KCE; Churchwell MD; Mauro VF; Boddu SHS
    Am J Health Syst Pharm; 2018 Apr; 75(8):510-512. PubMed ID: 29626000
    [No Abstract]   [Full Text] [Related]  

  • 9. Separation of 21-(R)- and 21-(S)-argatroban: solubility and activity of the individual diastereoisomers.
    Rawson TE; VanGorp KA; Yang J; Kogan TP
    J Pharm Sci; 1993 Jun; 82(6):672-3. PubMed ID: 8331548
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions of some commonly used drugs with human α-thrombin.
    Nair DG; Narayanan SP; Chittalakkottu S
    J Biomol Struct Dyn; 2015; 33(5):1008-15. PubMed ID: 24819365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of selected critical care drugs during simulated Y-site administration.
    Yamashita SK; Walker SE; Choudhury T; Iazzetta J
    Am J Health Syst Pharm; 1996 May; 53(9):1048-51. PubMed ID: 8744469
    [No Abstract]   [Full Text] [Related]  

  • 12. Visual compatibility of premixed theophylline or heparin with selected drugs for i.v. administration.
    Kershaw BP; Monnier HL; Mason JH
    Am J Hosp Pharm; 1993 Jul; 50(7):1360, 1362-3. PubMed ID: 8362868
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of inhibitory potency of argatroban toward thrombin by electrophoretically mediated microanalysis.
    Pochet L; Servais AC; Farcas E; Bettonville V; Bouckaert C; Fillet M
    Talanta; 2013 Nov; 116():719-25. PubMed ID: 24148466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual compatibility of doxapram hydrochloride with drugs commonly administered via a Y-site in the intensive care nursery.
    Bell MS; Nolt DH
    Am J Health Syst Pharm; 2003 Jan; 60(2):193-4. PubMed ID: 12561666
    [No Abstract]   [Full Text] [Related]  

  • 15. Compatibility of furosemide with 20% mannitol.
    Palmquist KL; Quattrocchi FP; Looney LA
    Am J Health Syst Pharm; 1995 Mar; 52(6):648, 650. PubMed ID: 7606581
    [No Abstract]   [Full Text] [Related]  

  • 16. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets.
    Allen LV; Levinson RS; Phisutsinthop D
    Am J Hosp Pharm; 1977 Sep; 34(9):939-43. PubMed ID: 20779
    [No Abstract]   [Full Text] [Related]  

  • 17. Compatibility of argatroban with selected cardiovascular agents.
    Honisko ME; Fink JM; Militello MA; Mauro VF; Alexander KS
    Am J Health Syst Pharm; 2004 Nov; 61(22):2415-8. PubMed ID: 15581266
    [No Abstract]   [Full Text] [Related]  

  • 18. Stability and compatibility of levofloxacin and metronidazole during simulated and actual Y-site administration.
    Sprandel KA; Styrczula DE; Deyo K; Sibley C; Rodvold KA
    Am J Health Syst Pharm; 2005 Jan; 62(1):88-92. PubMed ID: 15658079
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual compatibility of gallium nitrate with selected drugs during simulated Y-site injection.
    Lober CA; Dollard PA
    Am J Hosp Pharm; 1993 Jun; 50(6):1208-10. PubMed ID: 8517464
    [No Abstract]   [Full Text] [Related]  

  • 20. Visual compatibility of sodium nitroprusside with other injectable medications given to pediatric patients.
    Seto W; Trope A; Carfrae L; Walker S
    Am J Health Syst Pharm; 2001 Aug; 58(15):1422-6. PubMed ID: 11494788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.